Have Any Questions?

FAQ's

Remember, if you suspect you or a family member may have thalassemia or are a carrier, it is crucial to seek medical advice and undergo appropriate testing for accurate diagnosis and management.

Thalassemia may not always be detected through routine newborn screening. However, some states and countries include thalassemia in their newborn screening programs, enabling early diagnosis and timely intervention for affected infants.

Thalassemia can be identified during pregnancy through prenatal testing. If both parents are carriers, there are options available to manage the condition, including genetic counseling and prenatal diagnosis to make informed decisions about the pregnancy.

The life expectancy for individuals with thalassemia varies depending on the type and severity of the condition. With appropriate medical care and management, many individuals can lead fulfilling lives, but severe cases may have a shorter life expectancy.

Carriers of thalassemia, also known as “thalassemia trait,” usually do not show symptoms or have mild anemia. However, carriers can pass the defective gene to their children, increasing the risk of thalassemia in future generations.

Thalassemia is an autosomal recessive genetic disorder. This means that both parents must be carriers of the mutated gene for their child to be born with thalassemia. If both parents are carriers, each child has a 25% chance of having the condition.

Thalassemia is not curable, but it can be managed effectively with proper medical care. Treatments such as blood transfusions and iron chelation therapy can significantly improve the quality of life for affected individuals.

Thalassemia is an inherited blood disorder caused by mutations in specific genes that produce hemoglobin, leading to abnormal or reduced production of red blood cells. It primarily affects people of Mediterranean, Middle Eastern, Southeast Asian, and African descent.

Thalassemia has various types, including alpha-thalassemia and beta-thalassemia, each with different degrees of severity. The most severe form, beta-thalassemia major, requires lifelong medical management, including regular blood transfusions and iron chelation therapy.

Symptoms of thalassemia may include fatigue, weakness, pale skin, slow growth, and facial bone deformities. Untreated thalassemia can lead to serious complications such as organ damage due to iron overload, enlarged spleen, and heart problems.

Thalassemia can be diagnosed through blood tests and genetic testing. Genetic counseling is essential for individuals with a family history of thalassemia to understand the risk of passing the condition to their children and make informed reproductive decisions.

 

Treatment for thalassemia aims to manage symptoms and improve the quality of life. It may involve blood transfusions, iron chelation therapy to prevent iron overload, folic acid supplements, and in severe cases, bone marrow transplantation.

 

While thalassemia cannot be prevented, carriers can reduce the risk of passing the condition to their offspring through genetic testing and counseling. Additionally, prenatal testing can help identify thalassemia in the fetus, allowing parents to make informed decisions about the pregnancy.

Have Any Questions?

Facts about Thalassemia:

Remember, if you suspect you or a family member may have thalassemia or are a carrier, it is crucial to seek medical advice and undergo appropriate testing for accurate diagnosis and management.